Literature DB >> 9047250

Tumor spread and outcome of treatment in primary esophageal small cell carcinoma.

T Nishimaki1, T Suzuki, S Nakagawa, K Watanabe, K Aizawa, K Hatakeyama.   

Abstract

BACKGROUND: The most effective treatment for patients with esophageal small cell carcinoma has not yet been established because of the overall extremely poor prognosis regardless of the mode of treatment. The role of esophagectomy has been controversial in the management of patients with this disease.
METHODS: The clinicopathologic characteristics of 13 patients with primary esophageal small cell carcinoma were retrospectively studied and the prognostic significance of various factors with respect to esophagectomy were evaluated.
RESULTS: Lymph node metastases and distant metastases were found at the time of presentation in 92.3 and 46.2%, respectively. Two of nine patients treated by surgical resection for local-regional disease survived >5 years after radical esophagectomy with a projected 5-year survival rate of 22.2%. The remaining 4/13 patients were treated by nonsurgical modalities, but died of the disease within 10 months. A significant difference (P < 0.05) was detected between the survival curves of the two groups of patients.
CONCLUSION: Radical esophagectomy may be an effective treatment modality in improving survival and the odds of a cure in patients with local-regional small cell carcinoma of the esophagus.

Entities:  

Mesh:

Year:  1997        PMID: 9047250     DOI: 10.1002/(sici)1096-9098(199702)64:2<130::aid-jso8>3.0.co;2-c

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  12 in total

1.  A retrospective study of definitive chemoradiotherapy in patients with resectable small cell neuroendocrine carcinoma of the esophagus.

Authors:  Chikatoshi Katada; Shouko Komori; Tsutomu Yoshida; Shogo Kawakami; Akinori Watanabe; Kenji Ishido; Mizutomo Azuma; Takuya Wada; Kei Hosoda; Keishi Yamashita; Naoki Hiki; Satoshi Tanabe; Hiromichi Ishiyama; Wasaburo Koizumi
Journal:  Esophagus       Date:  2019-07-18       Impact factor: 4.230

2.  Small cell carcinoma of gastro-oesophageal junction with remarkable response to chemo-radiotherapy.

Authors:  Mototsugu Matsunaga; Keisuke Miwa; Tsuyoshi Noguchi; Yasutsuna Sasaki
Journal:  BMJ Case Rep       Date:  2012-07-25

3.  Clinicopathologic features and histochemical analyses of proliferative activity and angiogenesis in small cell carcinoma of the esophagus.

Authors:  Naohiko Koide; Hiroyasu Saito; Akira Suzuki; Toshiyuki Sato; Keiichiro Koiwai; Naoshi Nakamura; Shinichi Miyagawa
Journal:  J Gastroenterol       Date:  2007-12-25       Impact factor: 7.527

4.  Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma.

Authors:  Huan-Huan Wang; Nicholas G Zaorsky; Mao-Bin Meng; Zhi-Qiang Wu; Xian-Liang Zeng; Bo Jiang; Chao Jiang; Lu-Jun Zhao; Zhi-Yong Yuan; Ping Wang
Journal:  Onco Targets Ther       Date:  2015-02-13       Impact factor: 4.147

Review 5.  Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review.

Authors:  Emma Elizabeth Ilett; Seppo W Langer; Ingrid Holst Olsen; Birgitte Federspiel; Andreas Kjær; Ulrich Knigge
Journal:  Diagnostics (Basel)       Date:  2015-04-08

6.  Chemotherapy-induced small bowel perforation in a patient with extrapulmonary small-cell carcinoma of the small bowel.

Authors:  S Owen; M Chasen
Journal:  Curr Oncol       Date:  2008-12       Impact factor: 3.677

7.  Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases.

Authors:  B Brenner; M A Shah; M Gonen; D S Klimstra; J Shia; D P Kelsen
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

8.  Primary small cell carcinoma of the esophagus: clinicopathological study of 44 cases.

Authors:  Wei-Wei Chen; Feng Wang; Dong-Sheng Zhang; Hui-Yan Luo; Zhi-Qiang Wang; Feng-Hua Wang; Miao-Zhen Qiu; Chao Ren; Xiao-Li Wei; Wen-Jing Wu; Yu-Hong Li; Rui-Hua Xu
Journal:  BMC Cancer       Date:  2014-03-25       Impact factor: 4.430

9.  The 2002 AJCC TNM classification is a better predictor of primary small cell esophageal carcinoma outcome than the VALSG staging system.

Authors:  Sheng-Ye Wang; Wei-Ming Mao; Xiang-Hui Du; Ya-Ping Xu; Su-Zhan Zhang
Journal:  Chin J Cancer       Date:  2012-10-10

10.  Adjuvant Therapeutic Modalities in Primary Small Cell Carcinoma of Esophagus Patients: A Retrospective Cohort Study of Multicenter Clinical Outcomes.

Authors:  Bingwen Zou; Tao Li; Qiang Zhou; Daiyuan Ma; Yongshun Chen; Meijuan Huang; Feng Peng; Yong Xu; Jiang Zhu; Zhenyu Ding; Lin Zhou; Jin Wang; Li Ren; Min Yu; Youling Gong; Yanying Li; Longqi Chen; You Lu
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.